1. Kappas A, Sassa S, Galbraith RA, et al. The porphyrias. In: Scriver CR et al., editors. The metabolic basis of inherited disease. New York: McGraw-Hill; 1995. p. 2103–59.
2. Moran-Jimenez MJ, Ged C, Romana M, et al. Uroporphyrinogen decarboxylase: complete human gene sequence and molecular study of three families with hepatoerythropoietic porphyria. Am J Hum Genet. 1996;58(4):712–21.
3. Bonkovsky HL, Lambrecht RW, Shan Y. Iron as a co-morbid factor in nonhemochromatotic liver disease. Alcohol. 2003;30(2):137–44.
4. Shelly ED, Shelly WD, Burmeister V. Naproxen-induced pseudoporphyria presenting diagnostic dilemma. Cutis. 1987;40:314.
5. Rocchi E, Cassanelli M, Borghi A, et al. Liver iron overload and desferrioxamine treatment of porphyria cutanea tarda. Dermatologica. 1991;182(1):27–31.